References
- Ross SA, Boppana SB. Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis 2005;16:44–49.
- Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355–363.
- Enders G, Bäder U, Lindemann L, Schalasta G, Daiminger A. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001;21:362–377.
- Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006;35:216–220.
- Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol 2006;2:226e31.
- Nigro G, Adler SP. Cytomegalovirus infections in pregnancy. Curr Opin Obstet Gynecol 2011;23:123–128.
- Nelson CT, Demmler GJ. Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clin Perinatol 1997;24:151–160.
- La Torre R, Nigro G, Mazzocco M, Best AM, Adler SP. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006;43:994–1000.
- Abdel-Fattah SA, Bhat A, Illanes S, Bartha JL, Carrington D. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn 2005;25:1028–1031.
- Nigro G, Adler SP, La Torre R, Best AM; Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350–1362.
- Nigro G, Torre RL, Pentimalli H, Taverna P, Lituania M, de Tejada BM, Adler SP. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 2008;28:512–517.
- Nigro G, Adler SP, Parruti G, Anceschi MM, Coclite E, Pezone I, Di Renzo GC. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy – a case-control study of the outcome in children. J Infect Dis 2012;205:215–227, http://jid.oxfordjournals.org/.
- Jacquemard F, Yamamoto M, Costa JM, Romand S, Jaqz-Aigrain E, Dejean A, Daffos F, Ville Y. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007;114:1113–1121.
- Hill LM, Fries J, Hecker J, Grzybek P. Second-trimester echogenic small bowel: an increased risk for adverse perinatal outcome. Prenat Diagn 1994;14:845–850.
- MacGregor SN, Tamura R, Sabbagha R, Brenhofer JK, Kambich MP, Pergament E. Isolated hyperechoic fetal bowel: significance and implications for management. Am J Obstet Gynecol 1995;173:1254–1258.
- Muller F, Dommergues M, Aubry MC, Simon-Bouy B, Gautier E, Oury JF, Narcy F. Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome. Am J Obstet Gynecol 1995;173:508–513.
- Penna L, Bower S. Hyperechogenic bowel in the second trimester fetus: a review. Prenat Diagn 2000;20:909–913.
- Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, Rizzo N. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008;198:380.e1–380.e7.
- Al-Kouatly HB, Chasen ST, Streltzoff J, Chervenak FA. The clinical significance of fetal echogenic bowel. Am J Obstet Gynecol 2001;185:1035–1038.
- Al-Kouatly HB, Chasen ST, Karam AK, Ahner R, Chervenak FA. Factors associated with fetal demise in fetal echogenic bowel. Am J Obstet Gynecol 2001;185:1039–1043.